Clinically, DNA damage repair (DDR) inhibitors, including ATR inhibitors [44], ATM inhibitors [45], and DNA-PK inhibitors [46], have been applied to treat cancers like advanced solid cancers [47]. This evidence concerns the gene PRKDC and cancer.